G-protein based ELISA as a potency test for rabies vaccines
Authors:
Open Access
- 1 March 2017
- journal article
- Published by Elsevier in Biologicals
- Vol. 46, 124-129
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: State of the science and planning the way forwardBiologicals, 2012
- Alternative methods and strategies to reduce, refine, and replace animal use for human vaccine post-licensing safety testing: state of the science and future directionsProcedia in Vaccinology, 2011
- Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in HumansPLOS Neglected Tropical Diseases, 2009
- The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccinesBiologicals, 2009
- A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufactureBiologicals, 2006
- The human antibody repertoire specific for rabies virus glycoprotein as selected from immune librariesEuropean Journal of Immunology, 2005
- Use of ELISA forin vitroPotency Test of Rabies Vaccines for Animal UseBiologicals, 1996
- In vitro rabies vaccine potency appraisal by ELISA: Advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibodyBiologicals, 1990
- Characterization of a New Virus-neutralizing Epitope that Denotes a Sequential Determinant on the Rabies Virus GlycoproteinJournal of General Virology, 1989
- NIH test, a problematic method for testing potency of inactivated rabies vaccineVaccine, 1988